The pharmaceutical giant narrowed its full-year guidance after its blockbuster Wegovy weight-loss drug beat sales expectations in the third quarter.
Related Posts
Jamie Dimon’s Right-Hand Man Announces Retirement at JPMorgan
- staff
- January 14, 2025
- 0
Piepszak, who’s taking over as COO, has signaled that she doesn’t want to take the top job at the bank, people close to her said
Energy & Utilities Roundup: Market Talk
- staff
- January 21, 2025
- 0
Find insight on Orsted, Seatrium, Imdex and more in the latest Market Talks covering Energy and Utilities.
Activist Accuses Pfizer of Pressuring Former Executives
Starboard said a former CEO and CFO had assisted in its activist campaign but then were pressured to express support for the drugmaker.